NDC 47783-645 – Takhzyro
Lanadelumab 150 mg/mL · Solution · Subcutaneous
Product NDC47783-645
Product details
- Brand name
- Takhzyro
- Generic name
- lanadelumab-flyo
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761090
- Marketed since
- February 3, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Plasma Kallikrein Inhibitor
Active ingredients
- Lanadelumab 150 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 47783-645-01 | 1 SYRINGE, GLASS in 1 CARTON (47783-645-01) / 1 mL in 1 SYRINGE, GLASS | Feb 3, 2023 |
Other Takhzyro products
- 47783-646 Lanadelumab 300 mg/2mL · Solution · Takeda Pharmaceuticals America, Inc.